Immuneering (IMRX) Payables: 2020-2024
Historic Payables for Immuneering (IMRX) over the last 4 years, with Sep 2024 value amounting to $1.9 million.
- Immuneering's Payables rose 0.09% to $1.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $8.9 million, marking a year-over-year decrease of 14.88%. This contributed to the annual value of $2.1 million for FY2023, which is 33.06% down from last year.
- As of Q3 2024, Immuneering's Payables stood at $1.9 million, which was down 25.91% from $2.6 million recorded in Q2 2024.
- Over the past 5 years, Immuneering's Payables peaked at $3.2 million during Q4 2022, and registered a low of $1.2 million during Q2 2022.
- Over the past 3 years, Immuneering's median Payables value was $2.3 million (recorded in 2024), while the average stood at $2.2 million.
- As far as peak fluctuations go, Immuneering's Payables surged by 126.24% in 2022, and later slumped by 33.06% in 2023.
- Quarterly analysis of 5 years shows Immuneering's Payables stood at $1.5 million in 2020, then declined by 5.82% to $1.4 million in 2021, then skyrocketed by 126.24% to $3.2 million in 2022, then tumbled by 33.06% to $2.1 million in 2023, then rose by 0.09% to $1.9 million in 2024.
- Its Payables stands at $1.9 million for Q3 2024, versus $2.6 million for Q2 2024 and $2.3 million for Q1 2024.